Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1450662-05-1

Post Buying Request

1450662-05-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1450662-05-1 Usage

Class

Nicotinic acid derivative

Use

Intermediate in the synthesis of pharmaceutical products

Chemical properties

Two methoxy groups and one methyl group attached to the nicotinonitrile ring

Biological activities

Anti-inflammatory and anti-cancer properties

Potential

Candidate for the development of new drugs

Versatility

Building block for the synthesis of novel compounds with therapeutic applications

Check Digit Verification of cas no

The CAS Registry Mumber 1450662-05-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,5,0,6,6 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1450662-05:
(9*1)+(8*4)+(7*5)+(6*0)+(5*6)+(4*6)+(3*2)+(2*0)+(1*5)=141
141 % 10 = 1
So 1450662-05-1 is a valid CAS Registry Number.

1450662-05-1Relevant articles and documents

5-Hydroxyindole-based EZH2 inhibitors assembled via TCCA-catalyzed condensation and Nenitzescu reactions

Chen, Guoliang,Du, Fangyu,Sun, Wenjiao,Wang, Lihui,Wu, Chunfu,Yang, Cheng,Zhou, Qifan

supporting information, (2020/05/16)

5-Hydroxyindole derivatives have various demonstrated biological activities. Herein, we used 5-hydroxyindole as a synthetic starting point for structural alterations in a combinatorial process to synthesize 22 different compounds with EZH2 inhibitor pharmacophores. A series of 5-hydroxyindole-derived compounds were screened inhibitory activities against K562 cells. According to molecular modeling and in vitro biological activity assays, the preliminary structure-activity relationship was summarized. Compound L–04 improved both the H3K27Me3 reduction and antiproliferation parameters (IC50 = 52.6 μM). These findings revealed that compound L–04 is worthy of consideration as a lead compound to design more potent EZH2 inhibitors. During the preparation of compounds, we discovered that trichloroisocyanuric acid (TCCA) is a novel catalyst which demonstrates condensation-promoting effects. To gain insight into the reaction, in situ React IR technology was used to confirm the reactivity. Different amines were condensed in high yields with β-diketones or β-ketoesters in the presence of TCCA to afford the corresponding products in a short time (10~20 min), which displayed some advantages and provided an alternative condensation strategy.

IMIDAZOPYRIDINE EZH2 INHIBITORS

-

Page/Page column 122; 124, (2016/07/27)

The present invention relates to imidazopyridines of general formula (I), to a method for their preparation, to intermediates for their preparation, to pharmaceutical compositions comprising at least one of those compounds, and to the use thereof.

INDOLE DERIVATIVES AS MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

-

Paragraph 00154; 00158, (2015/02/25)

Agents of formulas (l)/(ll)/(lll) for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1450662-05-1